Exactech, Inc. (EXAC) Tops Q1 EPS by 1c; Guides In-Line

Exactech, Inc. (NASDAQ: EXAC) reported Q1 EPS of $0.30, $0.01 better than the analyst estimate of $0.29. Revenue for the quarter came in at $63.3 million versus the consensus estimate of $63.05 million.

Exactech, Inc. sees FY2014 EPS of $1.19-$1.24, versus the consensus of $1.2. Exactech, Inc. sees FY2014 revenue of $247-254 million, versus the consensus of $252.2 million.

First Quarter Segment Performance

• Knee implant revenue was constant at $20.6 million
• Extremity implant revenue increased 25% to $19.7 million
• Hip implant revenue increased 3% to $10.8 million
• Biologic and Spine revenue decreased 4% to $5.8 million
• Other revenue decreased 3% to $6.4 million

For earnings history and earnings-related data on Exactech, Inc. (EXAC) click here.

You May Also Be Interested In

• Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
• Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
• Digital Realty Trust (DLR) PT Raised to $229 at Bernstein SocGen Group